Opportunities Preloader

Please Wait.....

Report

United Kingdom Pharmaceutical Market, By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2027

Market Report I 2023-03-01 I 73 Pages I TechSci Research

United Kingdom pharmaceutical market is expected to register robust growth in the forecast period, 2023-2027. Innovations in the fields of oncology, autoimmune, and diabetes treatment will continue to augment the United Kingdom pharmaceutical market. Emerging markets will see a steady rise in people seeking treatment for these diseases owing to the advancements in treatments and prevention will continue to propel the market growth. A growing number of patients who experience chronic ailments or pain drives the market growth. In addition to this, chronic illnesses including hypertension and mental health issues are the key driver of the growth in the pharmaceutical market in United Kingdom. The pharmaceuticals that treat rare diseases as advancements in pharmaceuticals offer numerous solutions and up-gradations in medicine uncover more problems.
The Expanding Geriatric Population is Projected to Fuel the Market Growth
Chronic conditions are on the rise and patients are often suffering from more than just one ailment. This development is intensified owing to the growing middle-class and escalating adoption of sedentary lifestyles in emerging markets, which results in obesity, diabetes, and other costly health conditions. Chronic non-communicable disease prevalence such as cardiovascular diseases or cancer is accelerating the demand for pharmaceuticals. The increasing elderly population and the high requirement for more medical care especially for the older population are driving the growth of the pharmaceutical market. Government health programs including Medicaid and Medicare enable a wider range of seniors to be covered. Additionally, advancements in healthcare that people are living longer and requiring services for a longer period.
Growing Number of Chronic Diseases is Expected to Bolster the Market Growth
The escalating demand for healthcare and innovative solutions is one of the primary factors propelling market growth. Digitalization, big data, and artificial intelligence drive the transformation of the pharmaceutical sector and allow companies to enhance drug development and patient care beyond the treatment of diseases, which provides a new revenue stream. For patient care, digital solutions allow the shift from a disease focus to an integrated approach from prevention, screening, diagnostic, treatment, and aftercare. Continuous technological advancement and novel therapeutic approaches have the potential to not only treat but also assist in curing diseases - or identifying and eliminating risk factors before a disease develops. Part of this development is personalized therapies, a promising approach tailoring medical treatment to the individual characteristics of each patient. The emerging associations between the human microbiome, health, and disease are leading to novel diagnostics and therapeutics thereby improving personalized medicine. All these aforementioned factors are expected to augment the pharmaceutical market across United Kingdom during the forecast years.
Market Segmentation
The United Kingdom Pharmaceutical market is segmented into drug type, product type, application, distribution channel, regional distribution, and competitive landscape. Based on drug type, the market is bifurcated into generic drugs and branded drugs. Based on product type, the market is divided into prescription drugs and over-the-counter drugs. Based on application, the market is segmented into cardiovascular, musculoskeletal, oncology, anti-infective, metabolic disorder, and others. Based on end users, the market is divided into retail pharmacy, hospital pharmacy, and e-pharmacy. The United Kingdom pharmaceutical market is studied in major regions namely London, Southeast, East Anglia, Scotland, Southwest, East Midlands, Yorkshire & Humberside, Rest of United Kingdom.
Market Players
Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc., Vertex Pharmaceuticals (U.K.) Limited, Pfizer Limited, Novartis UK Limited, AstraZeneca UK Limited, Bristol-Myers Squibb Pharmaceuticals Limited, Roche Products Limited, Sanofi UK, and Sun Pharmaceuticals UK Limited are the key market players operating in United Kingdom Pharmaceutical market.
Report Scope:
In this report, United Kingdom Pharmaceutical market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- United Kingdom Pharmaceutical Market, By Drug Type:
o Generic Drugs
o Branded Drugs
- United Kingdom Pharmaceutical Market, By Product Type:
o Prescription Drugs
o Over-The-Counter Drugs
- United Kingdom Pharmaceutical Market, By Application:
o Cardiovascular
o Musculoskeletal
o Oncology
o Anti-infective
o Metabolic Disorder
o Others
- United Kingdom Pharmaceutical Market, By Distribution Channel:
o Retail Pharmacy
o Hospital Pharmacy
o E-Pharmacy
- United Kingdom Pharmaceutical Market, By Region:
o London
o Southeast
o East Anglia
o Scotland
o Southwest
o East Midlands
o Yorkshire & Humberside
o Rest of United Kingdom
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in United Kingdom Pharmaceutical market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
o Detailed analysis and profiling of additional market players (up to five).

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on United Kingdom Pharmaceutical Market
4. Executive Summary
5. Voice of Customer
6. United Kingdom Pharmaceutical Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)
6.2.2. By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)
6.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)
6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Product Market Map
7. United Kingdom Generic Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Application
7.2.3. By Distribution Channel
8. United Kingdom Branded Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Application
8.2.3. By Distribution Channel
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
11. Policy & Regulatory Landscape
12. United Kingdom Economic Profile
13. Competitive Landscape
13.1. Takeda Pharmaceutical Company Limited
13.2. GlaxoSmithKline Plc.
13.3. Vertex Pharmaceuticals (U.K.) Limited
13.4. Pfizer Limited
13.5. Novartis UK Limited
13.6. AstraZeneca UK Limited
13.7. Bristol-Myers Squibb Pharmaceuticals Limited
13.8. Roche Products Limited
13.9. Sanofi UK
13.10. Sun Pharmaceuticals UK Limited
14. Strategic Recommendations

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE